Skip to content
Tuesday, January 26, 2021
Latest:
  • Tips to manage OCD during COVID-19
  • Connecting the dots between lactating mother’s diet, milk composition, microbiome and benefits of mother’s milk
  • How does COVID-19 impact the thyroid?
  • Reducing COVID-19 vaccine hesitancy among racial and ethnic minorities
  • Waking up sleeping beauty – persistent IFN-gamma awakens and activates stem cells via BST2

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Connect With Us
  • bcm.edu

trastuzumab

From The Labs 

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019June 25, 2019 Ana Rodríguez 1 Comment Breast Cancer, Chemotherapy, Clinical Trials, HER2 gene, lapatinib, PI3K pathway, Research, trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs kicks off the new year with the most viewed Image of the Month of 2020.

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951